MR

Madhumita Rout

Active Director Director DIN 09526911
DIN 09526911 First appointment Mar 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2022
Shareholding value •••• Premium profile

About Madhumita Rout

Data last updated:

Madhumita Rout is a Director at Iheartvision Medicare Private Limited (since 2022). The company operates in Healthcare. Iheartvision Medicare Private Limited reported revenue of ₹1.77 Cr (FY 2025).

DIN 09526911
Primary Designation Director
Industry Healthcare
First Appointment 04 Mar 2022
Oldest Company Age 4 yrs
Largest company Iheartvision Medicare Private Limited · ₹1.77 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Mar 20222022₹1.77 Cr (FY 2025)Active

Board colleagues of Madhumita Rout

Directorship timeline

Open interactive timeline →
Iheartvision Medicare Private Limited
Premium access

Shareholding and investment profile for Madhumita Rout

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Madhumita Rout

Madhumita Rout currently holds 1 directorship: Iheartvision Medicare Private Limited (Director, since 04 Mar 2022, revenue ₹1.77 Cr (FY 2025)).

Madhumita Rout was first appointed on 04 Mar 2022 as Director at Iheartvision Medicare Private Limited.

The current boards of Madhumita Rout's companies include Gobinda Prasad Nayak (Iheartvision Medicare Private Limited), Kailash Chandra Rout (Iheartvision Medicare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available